David Meads

5.9k total citations · 1 hit paper
151 papers, 3.7k citations indexed

About

David Meads is a scholar working on Economics and Econometrics, General Health Professions and Public Health, Environmental and Occupational Health. According to data from OpenAlex, David Meads has authored 151 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Economics and Econometrics, 46 papers in General Health Professions and 24 papers in Public Health, Environmental and Occupational Health. Recurrent topics in David Meads's work include Health Systems, Economic Evaluations, Quality of Life (41 papers), Palliative Care and End-of-Life Issues (11 papers) and Healthcare Policy and Management (11 papers). David Meads is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (41 papers), Palliative Care and End-of-Life Issues (11 papers) and Healthcare Policy and Management (11 papers). David Meads collaborates with scholars based in United Kingdom, Switzerland and United States. David Meads's co-authors include Stephen P. McKenna, Lynda Doward, Judy Wright, John O’Dwyer, Natalie Doughty, Claire Hulme, Joanne Greenhalgh, José M Valderas, Elizabeth Gibbons and Sonia Dalkin and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

David Meads

144 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trial

2015 329 citations Laura C. Coates, Anna R. Moverley et al. profile →

Peers

Countries citing papers authored by David Meads

Since Specialization

Citations

This map shows the geographic impact of David Meads's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Meads with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Meads more than expected).

Fields of papers citing papers by David Meads

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Meads. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Meads. The network helps show where David Meads may publish in the future.

Co-authorship network of co-authors of David Meads

This figure shows the co-authorship network connecting the top 25 collaborators of David Meads. A scholar is included among the top collaborators of David Meads based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Meads. David Meads is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Adapting the EQ-5D-3L for adults with mild to moderate learning disabilities 2024 ·Health and Quality of Life Outcomes ·John O’Dwyer, Louise Bryant, Claire Hulme, Paul Kind, David Meads	2
2	Decision Making About Disease-Modifying Treatments for Relapsing-Remitting Multiple Sclerosis: Stated Preferences and Real-World Choices 2023 ·Patient ·Edward Webb, David Meads, (unknown), Helen Ford, Hilary Bekker, Jeremy Chataway, George Pepper, Joachim Marti, Yasmina Okan, Sue Pavitt, Klaus Schmierer, Ana Manzano	2
3	The informal carer experience during the COVID-19 pandemic: mental health, loneliness, and financial (in)-security 2023 ·White Rose Research Online (University of Leeds, The University of Sheffield, University of York) ·Edward Webb, David Meads, Clare Gardiner	3
4	COVID-19 and EQ-5D-5L health state valuation 2023 ·The European Journal of Health Economics ·Edward Webb, Paul Kind, David Meads, Adam Martin	2
5	Patient and carer access to medicines at end of life: the ActMed mixed-methods study 2022 ·SHILAP Revista de lepidopterología ·Sue Latter, (unknown), Jacqueline Birtwistle, Alison Richardson, Mike Bennett, David Meads, Alison Blenkinsopp, Liz Breen, Zoe Edwards, (unknown), (unknown), Sean Ewings, Miriam Santer, Lesley Roberts	4
6	Does a health crisis change how we value health? 2021 ·Health Economics ·Edward Webb, Paul Kind, David Meads, Adam Martin	17
7	The Prevention of Delirium system of care for older patients admitted to hospital for emergency care: the POD research programme including feasibility RCT 2021 ·SHILAP Revista de lepidopterología ·John Young, John R. Green, Mary Godfrey, Jane Smith, Francine Cheater, Claire Hulme, Michelle Collinson, Suzanne Hartley, Shamaila Anwar, (unknown), Gillian Santorelli, David Meads, (unknown), Najma Siddiqi, Dawn Brooker, Elizabeth Teale, Alex Brown, Anne Förster, Amanda Farrin, Sharon K. Inouye	3
8	Taking a local government perspective for economic evaluation of a population-level programme to promote exercise 2021 ·Health Policy ·Paolo Candio, David Meads, Andrew J. Hill, Laura Bojke	4
9	The Impact of Reproductive Issues on Preferences of Women with Relapsing Multiple Sclerosis for Disease-Modifying Treatments 2020 ·Patient ·Edward Webb, David Meads, (unknown), Helen Ford, Hilary Bekker, Jeremy Chataway, George Pepper, Joachim Marti, Yasmina Okan, Sue Pavitt, Klaus Schmierer, Ana Manzano	7
10	The decision-making process in recommending electronic communication aids for children and young people who are non-speaking: the I-ASC mixed-methods study 2020 ·SHILAP Revista de lepidopterología ·Janice Murray, (unknown), Juliet Goldbart, (unknown), Simon Judge, Edward Webb, (unknown), (unknown), Helen Whittle, (unknown), David Meads, Stephane Hess	11
11	Impact of communication on first treatment decisions in people with relapsing-remitting multiple sclerosis 2020 ·Patient Education and Counseling ·Ana Manzano, (unknown), Helen Ford, Hilary Bekker, Barbara Potrata, Jeremy Chataway, Klaus Schmierer, George Pepper, David Meads, Edward Webb, Sue Pavitt	11
12	Cost-effectiveness of a proportionate universal offer of free exercise: Leeds Let’s Get Active 2020 ·Journal of Public Health ·Paolo Candio, David Meads, Andrew J. Hill, Laura Bojke	4
13	Transforming discrete choice experiment latent scale values for EQ-5D-3L using the visual analogue scale 2020 ·The European Journal of Health Economics ·Edward Webb, John O’Dwyer, David Meads, Paul Kind, Penny Wright	17
14	Patient perspective on decisions to switch disease-modifying treatments in relapsing-remitting multiple sclerosis 2020 ·Multiple Sclerosis and Related Disorders ·Ana Manzano, (unknown), Helen Ford, Sue Pavitt, Barbara Potrata, Klaus Schmierer, Jeremy Chataway, Edward Webb, David Meads, George Pepper, Hilary Bekker	13
15	UK General Population Utility Values for the SIDECAR-D Instrument Measuring the Impact of Caring for People With Dementia 2020 ·Value in Health ·Edward Webb, David Meads, Hareth Al‐Janabi, Paul Kind, (unknown), Mike Horton, Jan R. Oyebode, Penny Wright	0
16	Effectiveness and cost-effectiveness of repeated implementation intention formation on adolescent smoking initiation: A cluster randomized controlled trial. 2019 ·Journal of Consulting and Clinical Psychology ·Mark Conner, Sarah Grogan, Robert West, Ruth Simms‐Ellis, (unknown), Bianca Sykes‐Muskett, Lisa Cowap, Rebecca Lawton, Christopher J. Armitage, David Meads, (unknown), Carole Torgerson, Kamran Siddiqi	17
17	What’s important in AAC decision making for children? Evidence from a best–worst scaling survey 2019 ·Augmentative and Alternative Communication ·Edward Webb, David Meads, (unknown), (unknown), Simon Judge, Juliet Goldbart, (unknown), (unknown), Stephane Hess, Janice Murray	20
18	Understanding treatment decisions from the perspective of people with relapsing remitting multiple Sclerosis: A critical interpretive synthesis 2018 ·Multiple Sclerosis and Related Disorders ·(unknown), Ana Manzano, George Pepper, Sue Pavitt, Helen Ford, Hilary Bekker, Jeremy Chataway, Klaus Schmierer, David Meads, Edward Webb, Barbara Potrata	24
19	Cost‐Effectiveness of Tight Control of Inflammation in Early Psoriatic Arthritis: Economic Analysis of a Multicenter Randomized Controlled Trial 2017 ·Arthritis Care & Research ·John O’Dwyer, David Meads, Claire Hulme, Lucy McParland, Sarah Brown, Laura C. Coates, Anna R. Moverley, Paul Emery, Philip G. Conaghan, Philip Helliwell	10
20	The responsiveness and validity of the CAMPHOR Utility Index 2008 ·European Respiratory Journal ·David Meads, Stephen P. McKenna, Natalie Doughty, Clare Das, Wendy Gin‐Sing, Jonathan Langley, (unknown)	42

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact